Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Vallejo-Fairfield, CA MSA — September 2026

Solano unemployment leads the Bay Area, but scientific pay holds firm.

Solano County's 5.5% unemployment rate is the highest in the Bay Area, yet metro Research Scientist pay of $151,191 still runs well above the $131,354 national median.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • Solano County unemployment: 5.5% — Highest of 9 Bay Area counties, up from 5.0% in June
  • MSA unemployment rate: 4.2% — September 2026, vs 4.1% national rate
  • Research Scientist advertised pay (metro): $151,191 — vs $131,354 national median, up significantly
  • California life sci consolidation signal: 117 roles — BioMarin Novato cuts planned for December 2026

Key takeaways

Solano County's weak headline number hides a scarcity story.

County unemployment at 5.5% outpaces every Bay Area peer, yet Research Scientist advertised pay locally runs nearly 15% above the national median. Broad labor slack is not translating into relief for specialized scientific roles.

Regulatory Affairs pay has gone flat, but scarcity hasn't eased.

Metro Regulatory Affairs Specialist pay sits stable at $109,176, tracking the national figure closely, even as national intelligence points to acute bottlenecks and VP-level regulatory compensation reaching $580K. Flat advertised pay at the specialist level may understate upward pressure building at senior regulatory tiers.

Clinical Data Manager and Validation Engineer pay are softening locally.

Both roles show moderate declines in metro advertised pay — Clinical Data Manager down to $139,084, Validation Engineer down to $105,512 — diverging from flat-to-rising national trends. Worth testing whether this reflects local demand softening or a shift toward outsourcing these functions to CROs.

BioMarin's Novato consolidation is a regional signal, not an isolated event.

117 planned cuts at BioMarin plus Amgen's July reduction point to established pharma consolidating in-state manufacturing and operational footprints. Vallejo-area leaders weighing build-vs-outsource manufacturing decisions should treat this as evidence the CDMO case is strengthening statewide, not just at the affected sites.

Median advertised pay by role — Vallejo-Fairfield, CA MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$115,348$151,191$162,813Significant increase$131,354
Clinical Research Associate$73,247$86,706$112,320Significant increase$90,956
Lab Technician *$44,720$52,416$57,803Moderate decline$47,402
Regulatory Affairs Specialist *$79,748$109,176$127,559Stable$104,000
Clinical Data Manager *$108,780$139,084$152,500Moderate decline$123,031
Biostatistician *$112,800$136,074$171,066Moderate increase$133,322
Validation Engineer$97,187$105,512$114,857Moderate decline$108,377

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Solano County's unemployment rate climbed to 5.5% in August — the highest among all nine Bay Area counties and nearly a full point above the national rate — even as the broader MSA rate held at 4.2% in September, reflecting a labor market where headline softness masks continued tightness in specialized roles. A DesigneRX Pharmaceuticals WARN filing for 25 workers in late September adds to a thin but visible stream of regional biopharma job actions, arriving alongside consolidation announcements at BioMarin and Amgen that signal California's established pharma employers are trimming headcount even as scientific and regulatory talent remains scarce.

What it means

Rising county-level unemployment combined with selective biopharma layoffs creates a market where broad labor supply is loosening but credentialed scientific, regulatory, and quality talent is not — a split that complicates headcount planning across R&D, clinical, and manufacturing functions. Metro Research Scientist pay at $151,191 against a national median of $131,354 suggests Vallejo-area employers are still paying a premium to secure scarce R&D talent even as macro conditions soften, while manufacturing consolidation trends documented statewide strengthen the case for CDMO/CRO reliance over in-house build-out. Organizations should evaluate whether current regulatory and R&D compensation positioning reflects local scarcity premiums rather than statewide softening, before assuming broader layoff activity will ease hiring pressure in these functions.

Looking ahead

Worth watching: Solano County's unemployment rate has risen three consecutive months (5.0% to 5.3% to 5.5%). Track whether this translates into a larger pool of displaced lab and clinical operations talent entering the regional candidate market over the next two reporting cycles.

Emerging pressure point: The DesigneRX WARN filing is small but may not be isolated — watch for additional Solano County biopharma WARN activity given the county's elevated unemployment trajectory relative to the rest of the Bay Area.

Potential inflection point: BioMarin's December Novato cuts and broader California manufacturing consolidation could release experienced CMC and quality talent into the Bay Area market by Q1 2027. Metro employers with open manufacturing or quality roles should monitor whether this eases a historically scarce specialty.

Expected: California's minimum wage rises to $17.40 on January 1, 2027, which will compress pay differentials for entry-level lab technician and support roles already showing moderate local pay declines. Review lower-band compensation structures ahead of the increase to avoid compression against skilled technician tiers.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.